BTMD

MKT CAP:$100M

biote Corp.

Market Cap

$100M

Healthcare·Medical - Care Facilities·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$2.22-$0.25 (-10.12%)

Apr 23, 2026

Company Details

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels...

CEO

Bret Christensen

IPO Date

Apr 28, 2021

Website

biote.com

Key Metrics TTM

Revenue

$145M

— YoY

Net Income

$33M

EPS (Diluted)

$4.37

Free Cash Flow

$29M

Revenue / Share

$19.14

Gross Margin

65.7%

Operating Margin

24.1%

Net Margin

22.8%

FCF Margin

20.0%

P/S

0.7x

P/E

3.0x

Earnings Reports

Q2 2022

May 6, 2026

PENDING

FY 2025

Mar 13, 2026

$192MEPS $0.74

FY 2023

Mar 15, 2024

$185MEPS $0.13

Q1 2022

May 20, 2022

$37M+17.8%EPS $1.23

FY 2021

Apr 6, 2022

$139M+19.6%EPS -$0.87

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 20	$31M	$20M	$10M
Q1 21	$32M	$20M	$9M
Q2 21	$35M	$23M	$10M
Q3 21	$36M	$23M	$9M
Q4 21	$38M	$24M	$6M
Q1 22	$37M	$25M	$10M

Valuation

Quarter	P/S	P/E
Q4 20	—	—
Q1 21	—	—
Q2 21	—	—
Q3 21	0.8x	2.7x
Q4 21	0.7x	3.1x
Q1 22	0.7x	3.0x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 20	$7M	$7M
Q1 21	$8M	$8M
Q2 21	$9M	$8M
Q3 21	$6M	$5M
Q4 21	$10M	$9M
Q1 22	$7M	$6M

Capital Expenditures

Quarter	CapEx
Q4 20	$194.0K
Q1 21	$142.0K
Q2 21	$879.0K
Q3 21	$1M
Q4 21	$1M
Q1 22	$482.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 21	+21.7%	+52.0%
Q1 22	+17.8%	+23.6%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 20	$0	0.0%
Q1 21	$0	0.0%
Q2 21	$0	0.0%
Q3 21	$0	0.0%
Q4 21	$0	0.0%
Q1 22	$0	0.0%

OpEx Breakdown

Quarter	G&A	S&M
Q4 20	$8M	$1M
Q1 21	$9M	$1M
Q2 21	$11M	$1M
Q3 21	$12M	$1M
Q4 21	$16M	$2M
Q1 22	$15M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$72M	$0	$72M
Q2 22	$83M	$0	$83M
Q3 22	$77M	$0	$77M
Q4 22	$79M	$0	$79M
Q1 23	$88M	$0	$88M
Q2 23	$68M	$20M	$88M
Q3 23	$66M	$20M	$86M
Q4 23	$89M	$0	$89M
Q1 24	$79M	$0	$79M
Q2 24	$26M	$0	$26M
Q3 24	$38M	$0	$38M
Q4 24	$39M	$0	$39M
Q1 25	$42M	$0	$42M
Q2 25	$20M	$0	$20M
Q3 25	$28M	$0	$28M
Q4 25	$24M	$0	$24M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 20	8M	—	—
Q1 21	8M	0.0%	—
Q2 21	8M	0.0%	—
Q3 21	8M	0.0%	—
Q4 21	8M	0.0%	0.0%
Q1 22	8M	0.0%	0.0%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 20	—	—
Q1 21	—	—
Q2 21	—	—
Q3 21	—	—
Q4 21	$9M	4
Q1 22	$9M	4

Revenue / Employee